Small Biotech Catapults To Record High On $10.6 Billion Deal Investor’s Business DailyNuvalent shares surge 39% after UK’s GSK agrees to buy the cancer drugmaker for $10.6 billion CNBCGSK enters agreement to acquire Nuvalent, Inc. GSKGSK to Buy Nuvalent for $10.6 Billion in Oncology Push WSJGSK makes biggest ever acquisition with $10.6bn for US cancer drug firm The Guardian